A naukri.com initiative
Bioengineer
8h
197
Image Credit: Bioengineer
Revolutionary Dual Stem Cell Therapy Introduced for Combating Brain Metastasis in Non-Small Cell Lung Cancer Patients
- Scientists are exploring innovative stem cell treatment strategies for leptomeningeal brain metastasis (LBM), a manifestation of metastatic brain cancer.
- Traditional therapies, like chemotherapy, have been deemed inadequate against LBM, spotlighting the need for innovative methods to combat this disease.
- Researchers have developed immune-competent LBM mice models to create a reliable framework for testing new treatment protocols.
- They investigated the potential of using allogeneic dual stem cells engineered to release oncolytic herpes simplex virus (oHSV) and anti-PD-1 (scFvPD-1) to augment tumor cell destruction and modulate the immunological environment surrounding tumors.
- The application of dual stem cells showed notable improvements in therapeutic outcomes, primarily due to the induction of immunogenic cell death—a process crucial for stimulating the body’s immune response against tumors.
- Further, the treatment activated anti-tumor T cell signaling pathways, changing the way the body fights back against the cancerous cells and made the tumors sensitive to cisplatin, a chemotherapy drug commonly used for cancers.
- The findings could be transformative for LBM patients, demonstrating that localized delivery of a combination of engineered stem cells could significantly enhance treatment efficacy.
- The research also showcases the importance of collaboration across various scientific fields—combining cancer biology, immunology, and innovative engineering—demonstrating how interdisciplinary approaches can advance the fight against cancer.
- The role of stem cell technology in developing effective therapies for complex conditions like LBM illustrates how far treatment paradigms have evolved, moving from traditional chemotherapy to more nuanced, targeted therapies.
- The promise of dual stem cell-based immunotherapy highlights a new frontier in cancer treatment, offering transformative therapies that address both the biological complexities of cancer and the therapeutic challenges posed by metastasis.
Read Full Article
11 Likes
For uninterrupted reading, download the app